Webinars

Choose from a variety of resources to get a better understanding of Syngene’s point of view, expertise or approach to drug discovery, development and manufacturing to ensure client success.

Resource Types

ADME strategy and challenges: Heterobifunctional degraders

Heterobifunctional protein degraders like PROTACs are one of the most important types of targeted protein degraders. However, beyond the rule of 5 nature of these compounds introduces distinct ADME challenges not commonly encountered with smaller molecules. These challenges include poor solubility, low permeability, inadequate recoveries in in vitro ADME assays, high protein binding, and weak in vitro-to-in vivo correlation (IVIVC). This webinar focuses on ADME strategy and challenges in developing heterobifunctional degraders and the possible solutions to overcome hurdles.

SynWeaveTM: Integrating Speed, Titer and Quality webinar

SynWeave™ leverages state-of-the-art cell line and transposon-based technologies from ExcellGene, seamlessly integrated with Syngene’s advanced process development capabilities. This synergy dramatically enhances manufacturability and efficiency, ensuring faster and more reliable protein production

Rapid Discovery: Accelerate drug discovery from Hit ID to the Clinic

In this joint webinar with Axcelead, you will learn the ‘right’ approach to high throughput screening (HTS) to enable rapid drug discovery. Other topics include leveraging data-intensive tools like AI-ML to accelerate drug discovery across target identification, drug repurposing, DMTA cycles, etc.

Drug Repurposing: Perspective on an emerging pharmaceutical solution

Learn from our client PharmAust, how drug repurposing is an effective alternative approach to traditional drug discovery, the changing landscape of drug repurposing, steps in the drug repurposing journey when moving up to GMP scale and more.

Creating the RIGHT toxicology strategy: Learning from the past to shape the future

Learn from our client ApconiX, the key trends in the toxicology space, how AI and in vitro studies co-exist and support an overarching tox strategy and more.

Interpreting Clinical Relevance of Immunogenicity Data Syngene

Learn from our client, Merck & Co., the relevance of PK and ADA data in a clinical setting, impact of neutralizing antibodies on PK and more.

Targeted Protein Degradation

Listen to what our client, C4 Therapeutics has to say, about the exciting opportunity that Targeted Protein Degradation represents to Biopharma companies around the world.

Advancing molecules from discovery to the clinic: A blueprint

Our client, Albireo, recently cleared phase-3 clinical trials for its drug Odevixibat. Learn from Albireo’s experience, how to advance molecules from discovery to the clinic in the shortest possible time.

Building a successful ICH Stability CoE: Collaborating at scale

Syngene-Baxter R& D Centre is going strong even after 10 years. Undertand from our experts, the key elements of a great research partnership in ICH Stability Studies.

Discovery

Development

Manufacturing

Discovery

Development & Manufacturing

SynVent Integrated Drug Discovery

Emerging Biopharma

Dedicated Centers

Center for Advanced Protein Studies (CAPS)

Investors

Corporate Governance

Webinars

Resource Types

ADME strategy and challenges: Heterobifunctional degraders

SynWeaveTM: Integrating Speed, Titer and Quality webinar

Rapid Discovery: Accelerate drug discovery from Hit ID to the Clinic

Drug Repurposing: Perspective on an emerging pharmaceutical solution

Creating the RIGHT toxicology strategy: Learning from the past to shape the future

Interpreting Clinical Relevance of Immunogenicity Data Syngene

Targeted Protein Degradation

Advancing molecules from discovery to the clinic: A blueprint

Building a successful ICH Stability CoE: Collaborating at scale

Sign-up for our newsletter

Quick links

Business

Get in touch

Other links

To view or email, Please share your details view

To download, Please share your details

To view or email, Please share your details view

To download, Please share your details